Literature DB >> 22190037

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.

Stefanie Jäger1, Dong Young Kim, Judd F Hultquist, Keisuke Shindo, Rebecca S LaRue, Eunju Kwon, Ming Li, Brett D Anderson, Linda Yen, David Stanley, Cathal Mahon, Joshua Kane, Kathy Franks-Skiba, Peter Cimermancic, Alma Burlingame, Andrej Sali, Charles S Craik, Reuben S Harris, John D Gross, Nevan J Krogan.   

Abstract

Restriction factors, such as the retroviral complementary DNA deaminase APOBEC3G, are cellular proteins that dominantly block virus replication. The AIDS virus, human immunodeficiency virus type 1 (HIV-1), produces the accessory factor Vif, which counteracts the host's antiviral defence by hijacking a ubiquitin ligase complex, containing CUL5, ELOC, ELOB and a RING-box protein, and targeting APOBEC3G for degradation. Here we reveal, using an affinity tag/purification mass spectrometry approach, that Vif additionally recruits the transcription cofactor CBF-β to this ubiquitin ligase complex. CBF-β, which normally functions in concert with RUNX DNA binding proteins, allows the reconstitution of a recombinant six-protein assembly that elicits specific polyubiquitination activity with APOBEC3G, but not the related deaminase APOBEC3A. Using RNA knockdown and genetic complementation studies, we also demonstrate that CBF-β is required for Vif-mediated degradation of APOBEC3G and therefore for preserving HIV-1 infectivity. Finally, simian immunodeficiency virus (SIV) Vif also binds to and requires CBF-β to degrade rhesus macaque APOBEC3G, indicating functional conservation. Methods of disrupting the CBF-β-Vif interaction might enable HIV-1 restriction and provide a supplement to current antiviral therapies that primarily target viral proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190037      PMCID: PMC3310910          DOI: 10.1038/nature10693

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

Review 1.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Authors:  Michael H Malim; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

2.  Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate.

Authors:  Kenneth Wu; Jordan Kovacev; Zhen-Qiang Pan
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

3.  Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.

Authors:  Bradford J Stanley; Elana S Ehrlich; Leslie Short; Yunkai Yu; Zuoxiang Xiao; Xiao-Fang Yu; Yong Xiong
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

Review 5.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

6.  Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.

Authors:  Jason L DeHart; Alberto Bosque; Reuben S Harris; Vicente Planelles
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

7.  Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Authors:  Fransje A Koning; Edmund N C Newman; Eun-Young Kim; Kevin J Kunstman; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification.

Authors:  Danny T Huang; Olivier Ayrault; Harold W Hunt; Asad M Taherbhoy; David M Duda; Daniel C Scott; Laura A Borg; Geoffrey Neale; Peter J Murray; Martine F Roussel; Brenda A Schulman
Journal:  Mol Cell       Date:  2009-02-27       Impact factor: 17.970

9.  APOBEC3 proteins mediate the clearance of foreign DNA from human cells.

Authors:  Mark D Stenglein; Michael B Burns; Ming Li; Joy Lengyel; Reuben S Harris
Journal:  Nat Struct Mol Biol       Date:  2010-01-10       Impact factor: 15.369

10.  Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.

Authors:  Anjanabha Saha; Raymond J Deshaies
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

View more
  204 in total

1.  HIV: Tagged for destruction.

Authors:  Sheilagh Molloy
Journal:  Nat Rev Microbiol       Date:  2012-01-16       Impact factor: 60.633

2.  Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Authors:  Zaza M Ndhlovu; Jacqueline Proudfoot; Kevin Cesa; Donna Marie Alvino; Ashley McMullen; Seanna Vine; Eleni Stampouloglou; Alicja Piechocka-Trocha; Bruce D Walker; Florencia Pereyra
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

3.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

4.  HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Authors:  Judd F Hultquist; Rebecca M McDougle; Brett D Anderson; Reuben S Harris
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-13       Impact factor: 2.205

5.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

6.  Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.

Authors:  Erez Pery; Ann Sheehy; N Miranda Nebane; Andrew Jay Brazier; Vikas Misra; Kottampatty S Rajendran; Sara J Buhrlage; Marie K Mankowski; Lynn Rasmussen; E Lucile White; Roger G Ptak; Dana Gabuzda
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

7.  CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Authors:  Eri Miyagi; Sandra Kao; Venkat Yedavalli; Klaus Strebel
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.

Authors:  Jason D Salter; Geoffrey M Lippa; Ivan A Belashov; Joseph E Wedekind
Journal:  Biochemistry       Date:  2012-10-25       Impact factor: 3.162

9.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

10.  The Impact of Mass Spectrometry-Based Proteomics on Fundamental Discoveries in Virology.

Authors:  Todd M Greco; Benjamin A Diner; Ileana M Cristea
Journal:  Annu Rev Virol       Date:  2014-07-14       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.